-
公开(公告)号:SG172266A1
公开(公告)日:2011-07-28
申请号:SG2011044922
申请日:2009-12-17
Applicant: GENENTECH INC , INST MEDICAL W & E HALL , ABBOTT LAB
Inventor: BAELL JONATHAN BAYLDON , BUI CHINH THIEN , COLMAN PETER , DUDLEY DANETTE A , FAIRBROTHER WAYNE J , FLYGARE JOHN A , LESSENE GUILLAUME LAURENT , NDUBAKU CHUDI , NIKOLAKOPOULOS GEORGE , RYE CARL STEVEN , SLEEBS BRAD EDMUND , SMITH BRIAN JOHN , WATSON KEITH GEOFFREY , ELMORE STEVEN W , PETROS ANDREW M , SOUERS ANDREW J , CZABOTAR PETER
Abstract: In one aspect, the present invention provides for a compound of Formula (I) in which, the variables X1, X2a, X2b, X2c, R1, B, L, E, A and the subscript n are as defined herein. In another aspect, the present invention provides for pharmaceutical compositions comprising compounds of Formula (I) as well as methods for using compounds of Formula (I) for the treatment of diseases and conditions (e.g., cancer, thrombocythemia, etc) characterized by the expression or over-expression of Bcl-2 anti-apoptotic proteins, e.g., of anti-apoptotic Bcl-xL proteins.
-
72.
公开(公告)号:MX2011005925A
公开(公告)日:2011-06-16
申请号:MX2011005925
申请日:2009-12-04
Applicant: ABBOTT LAB
Inventor: WANG GARY T , HEXAMER LAURA , SULLIVAN GERARD M , TAO ZHI-FU , WANG LE , BRUNCKO MILAN , KUNZER AARON R , WENDT MICHAEL D , DAI YUJIA , DING HONG , WANG XILU , MCCLELLAN WILLIAM J , SOUERS ANDREW J , SONG XIAOHONG , PARK CHEOL-MIN , MANTEI ROBERT A , DOHERTY GEORGE A , MORE STEVEN W , HASVOLD LISA , PARK CHANG H , PETROS ANDREW M
IPC: A61K31/496 , A61P35/00 , C07D403/12
Abstract: Se describen compuestos que inhiben la actividad de proteínas anti-apoptóticas BcI-2, composiciones que contienen los compuestos y métodos para tratar enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2.
-
公开(公告)号:UY32305A
公开(公告)日:2010-07-30
申请号:UY32305
申请日:2009-12-07
Applicant: ABBOTT LAB
Inventor: WANG GARY T , MANTEI ROBERT A , MILAN BRUNCKO , HONG DING , DOHERTY GEORGE A , ELMORE STEVEN W , LISA HASVOLD , LAURA HEXAMER , KUNZER AARON R , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , XIAOHONG SONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , LE WANG , XILU WANG , WENDT MICHAEL D
IPC: A61K31/635 , A61P35/00 , C04B35/632 , C07C311/51 , C07D211/44 , C07D213/00 , C07D295/14 , C07D413/12
Abstract: Compuestos que inhiben la actividad de las proteínas anti-apoptóticas Bcl-2 o Bc1-XL, composiciones que contienen dichos compuestos y métodos para tratar enfermedades durante las cuales se expresa la proteína anti-apoptótica Bcl-2
-
公开(公告)号:ES2330834T3
公开(公告)日:2009-12-16
申请号:ES01987213
申请日:2001-11-15
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , PETROS ANDREW M , YOON HO-SUP , NETTESHEIM DAVID G
IPC: C07K14/47 , G01N33/50 , G01N33/15 , G01N33/566
Abstract: Una proteína mutante derivada de una proteína Bcl-2 humana de tipo salvaje y que tiene una secuencia de aminoácidos que comprende la SEC ID Nº:2, en la cual una secuencia de residuos de aminoácidos que codifica un bucle flexible de dicha proteína Bcl-2 humana de tipo salvaje que comprende los aminoácidos 35-91 de dicha proteína Bcl-2 humana, está sustituida por una secuencia de aminoácidos de sustitución que comprende la secuencia de la SEC ID Nº:1.
-
公开(公告)号:DE60139889D1
公开(公告)日:2009-10-22
申请号:DE60139889
申请日:2001-11-15
Applicant: ABBOTT LAB
Inventor: FESIK STEPHEN W , PETROS ANDREW M , YOON HO-SUP , NETTESHEIM DAVID G
IPC: C07K14/47 , G01N33/50 , G01N33/15 , G01N33/566
-
公开(公告)号:BR0110101A
公开(公告)日:2005-06-07
申请号:BR0110101
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A , DICKMAN DANIEL A , DING HONG , DINGES JURGEN , FESIK STEPHEN W , HAJDUK PHILIP J , KUNZER AARON R , NETTESHEIM DAVID G , PETROS ANDREW M , ROSENBERG SAUL H , SHEN WANG , THOMAS SHEELA A , WENDT MICHAEL D
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07C311/00
-
公开(公告)号:PE20020504A1
公开(公告)日:2002-06-20
申请号:PE2001000940
申请日:2001-09-19
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , WANG XILU , BAUMEISTER STEVEN A , DING HONG , FESIK STEPHEN W , KUNZER AARON R , PETROS ANDREW M , WENDT MICHAEL D , THOMAS SHEELA A , SHEN WANG , ROSEMBERG SAUL H , NETTERSHEIM DAVID G , HAJDUK PHILIP J , DINGES JURGEN , DICKMAN DANIEL A , AUGERI DAVID J , BRUNCKO MILAN
IPC: C07C311/00 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/12 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: SE REFIERE A N-ACILSULFONAMIDAS DE FORMULA I DONDE A ES FENILO, ANILLO CARBOCICLICO AROMATICO DE 5-6 MIEMBROS; R1 ES ALQUILO, HALOALQUILO, NITRO, NR5R6; R2 Y R3 SON H, ALQUENILO, ALCOXI, ALQUILO, ALQUILSULFANILO, ALQUINILO, ARILO, ARILALCOXI, ENTRE OTROS; R4 ES ARILO, ARILALQUENILO, ARILALCOXI, ARILOXI, ARILOXIALCOXI, ENTRE OTROS; R5 Y R6 SON HIDROGENO, ALQUENILO, ALCOXIALQUILO, ENTRE OTROS; R5 Y R6 JUNTO A N FORMAN UN IMIDAZOLILO, MORFOLINILO, PIPERAZINILO, PIPERIDINILO, ENTRE OTROS; R15 ES H, ALQUILO, HALO. SON COMPUESTOS PREFERIDOS 4-((2,2-DIMETILCICLOPENTIL)AMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, 4-(CICLOHEXILAMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON PROMOTORES DE LA APOPTOSIS Y SON UTILES PARA EL TRATAMIENTO DEL CANCER
-
公开(公告)号:CA2427658A1
公开(公告)日:2002-05-23
申请号:CA2427658
申请日:2001-11-15
Applicant: ABBOTT LAB
Inventor: PETROS ANDREW M , FESIK STEPHEN W , NETTESHEIM DAVID G , YOON HOSUP
IPC: G01N33/50 , C07K14/47 , G01N33/15 , G01N33/566
Abstract: Mutant peptides derived from wild-type human Bcl-2 are disclosed. Assays to identify substances which block the ability of Bcl-2 to inhibit apoptosis al so are disclosed.
-
-
-
-
-
-
-